Paper Details

  1. Home
  2. Paper Details

PA32540 for the secondary prevention of cardiovascular disease in patients at risk for aspirin-associated gastric ulcers.

Author: AdamsSuzanne, DuffyDanielle, RooneyBridget, WhellanDavid J

ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Aspirin is widely used to prevent cardiovascular disease but comes with risks of bleeding and gastrointestinal problems. A polypill containing aspirin and a proton pump inhibitor, PA32540, shows promising safety and efficacy in preliminary trials.
Paper Details　
Original Abstract of the Article :
Prescribed in patients with a history of myocardial infarction, stroke, transient ischemic attack, coronary intervention or bypass surgery, aspirin is one of the medications most commonly used in the secondary prevention of cardiovascular diseases. It has become a mainstay of therapy after years of ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4743601/

データ提供：米国国立医学図書館（NLM）

Aspirin's Journey: Balancing Benefits and Risks

Cardiovascular disease research is a vast desert, and researchers are constantly searching for oases of effective treatments. This study delves into the world of aspirin, a common medication for secondary prevention of cardiovascular diseases. While aspirin has proven its worth in countless clinical trials, it’s not without its thorns – it can cause bleeding and gastrointestinal issues. The researchers explore different strategies to mitigate these side effects, including the development of combination formulations like PA32540. This polypill, which combines aspirin with a proton pump inhibitor, shows promising results in early clinical trials.

A Promising Solution for Aspirin's Side Effects

The study suggests that PA32540 could be a valuable tool for expanding the population that can safely benefit from aspirin therapy. The combination of aspirin and a proton pump inhibitor in a single pill could improve adherence to treatment and reduce the risk of gastrointestinal side effects.

Navigating Aspirin Therapy: A Balancing Act

Aspirin is a powerful tool in the fight against cardiovascular disease, but it's essential to weigh the potential benefits against the risks. This research highlights the importance of developing new strategies to optimize aspirin therapy and make it more accessible to a wider population.

Dr.Camel's Conclusion

This research is a shining beacon in the desert of cardiovascular disease research. It shows the potential of innovative approaches to address the challenges of aspirin therapy. PA32540 could be a valuable addition to the medical toolkit, offering a safer and more effective way to prevent cardiovascular disease.

Date :
  1. Date Completed 2015-08-14
  2. Date Revised 2021-10-21
Further Info :

Pubmed ID

25300316

DOI: Digital Object Identifier

PMC4743601

Related Literature

Article Analysis
・Side Effects of aspirin and omeprazole
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.